|
Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice with Transplant of Purified Donor Blood Stem Cells
April 23, 2007
Cellerant Therapeutics Presents Positive Preclinical Data on
Purified Blood-Forming Stem Cells at ASH
December 12, 2006
Cellerant Therapeutics Appoints Ramkumar Mandalam as Vice President of Pharmaceutical Operations
November 1, 2005
Cellerant Adds $9 Million to Series B Round for a Total of $25 Million
September 22, 2005
FierceBiotech Honors Cellerant Therapeutics as One of the “Fierce 15" Biotech Companies of 2005
June 21, 2005
Cellerant Therapeutics Raises $16 million to advance stem cell-based therapies for life-threatening diseases
May 11, 2005
Cellerant Therapeutics has moved
May 2, 2005
Cellerant Therapeutics Profiled in Nature Bioentrepreneur (registration required)
February 24, 2005
Cellerant Therapeutics Presents Preclinical Data Demonstrating Therapeutic Benefit of Expanded Myeloid Progenitors at 2005 Tandem BMT Meetings
February 14, 2005
Cellerant Therapeutics Announces Publication Confirming Activity of Myeloid Progenitor Cells in Mouse Model of Chemotherapy-Induced Neutropenia
December 7, 2004
European Patent Office Grants Cellerant Therapeutics Broad Claims on the Human Hematopoietic Stem Cell
October 28, 2004
Cellerant Therapeutics Awarded NIH Grant to Develop Human Hematopoietic Stem and Progenitor Cells for Biodefense Applications
September 29, 2004
|
